المؤلفون: Yang Meng, Neil Roskell, Andrew Walker, Helen Johnson, D. Lee, John Ellis, Zoe Philips, N. Hertel, E. Morais

المصدر: Meng, Y, Hertel, N, Ellis, J, Morais, E, Johnson, H, Philips, Z, Roskell, N, Walker, A & Lee, D 2018, ' The cost-effectiveness of nivolumab monotherapy for the treatment of advanced melanoma patients in England ', The European Journal of Health Economics, vol. 19, no. 8, pp. 1163-1172 . https://doi.org/10.1007/s10198-018-0964-4Test

مصطلحات موضوعية: Male, Oncology, Skin Neoplasms, Cost effectiveness, Cost-Benefit Analysis, Economics, Econometrics and Finance (miscellaneous), Kaplan-Meier Estimate, Antineoplastic Agents, Immunological, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, Oximes, Skin Neoplasms/drug therapy, Melanoma/drug therapy, 030212 general & internal medicine, Vemurafenib, Melanoma, Health Policy, Imidazoles, Age Factors, Ipilimumab/economics, Middle Aged, Markov Chains, Nivolumab/administration & dosage, Dacarbazine, Nivolumab, Models, Economic, Health Resources/economics, 030220 oncology & carcinogenesis, Disease Progression, Health Resources, Female, Quality-Adjusted Life Years, medicine.drug, Proto-Oncogene Proteins B-raf, medicine.medical_specialty, Imidazoles/economics, Ipilimumab, Disease-Free Survival, 03 medical and health sciences, Sex Factors, Antineoplastic Agents, Immunological/administration & dosage, Internal medicine, Proto-Oncogene Proteins B-raf/genetics, medicine, Humans, Oximes/economics, Survival analysis, Aged, business.industry, Vemurafenib/economics, Dacarbazine/economics, Dabrafenib, Clinical trial, Health Expenditures, business, Antineoplastic Combined Chemotherapy Protocols/economics

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fbba7ec0a8309e03b0b8e6ffb8f01a95Test
https://doi.org/10.1007/s10198-018-0964-4Test

المؤلفون: Vincent Pillonel, Olivier Michielin, Andreas F. Hottinger, Luis Schiappacasse, Veronica Aedo-Lopez, Gregoire Berthod, Vincent Dunet, Solange Peters

المصدر: Journal for Immunotherapy of Cancer
Journal for immunotherapy of cancer, vol. 7, no. 1, pp. 336
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-6 (2019)

مصطلحات موضوعية: 0301 basic medicine, Oncology, Adult, Male, Cancer Research, medicine.medical_specialty, medicine.medical_treatment, CNS demyelination, Immunology, Remission, Spontaneous, Spontaneous remission, Case Report, Metastatic melanoma, lcsh:RC254-282, Asymptomatic, 03 medical and health sciences, Immune checkpoint inhibitors, 0302 clinical medicine, Antineoplastic Agents, Immunological, Immune related adverse events, Internal medicine, medicine, Image Processing, Computer-Assisted, Immunology and Allergy, Humans, Antineoplastic Agents, Immunological/administration & dosage, Antineoplastic Agents, Immunological/adverse effects, Asymptomatic Diseases, Demyelinating Diseases/diagnosis, Demyelinating Diseases/etiology, Magnetic Resonance Imaging, Melanoma/complications, Melanoma/diagnosis, Melanoma/drug therapy, Nivolumab/administration & dosage, Nivolumab/adverse effects, Neurological toxicities, Nivolumab, Melanoma, Pharmacology, business.industry, Immunotherapy, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.disease, Hyperintensity, 030104 developmental biology, 030220 oncology & carcinogenesis, Molecular Medicine, medicine.symptom, business, Demyelinating Diseases

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::405a051ce719beb9bfa688acb52fdc90Test
https://pubmed.ncbi.nlm.nih.gov/31791418Test